why choose us

First received: October 12, 2023

Clinical Trial: Safety & Efficacy of Thalidomide in Children With Transfusion Dependent Thalassemia

Study Status: Completed

Recruit Status: RECRUITING

Condition: Transfusion-dependent Thalassemia

Study Type: INTERVENTIONAL


Official Title: Safety & Efficacy of Thalidomide in Children With Transfusion Dependent Thalassemia: a Quasi Randomized Control Trial in a Tertiary Care Hospital in Bangladesh

Brief Summary: Transfusion Dependent Thalassemia (TDT) is emerging as a global public health concern.Hemopoietic stem cell transplantation (HSCT) is the only curative treatment.But its adoption is limited due to lack of Human leukocyte antigen (HLA) matched donor, experienced centers and high initial cost.So, researches are going on in search of an effective, safe, easily available treatment option.Thalidomide a Fetal Hemoglobin (HbF) inducing drug shown to be effective in treatment of TDT patients in few case reports and small…

Read more